Treatment of established osteoporosis: a systematic review and cost-utility analysis
Main Authors: | J.A. Kanis, J. E. Brazier, M. Stevenson, N.W. Calvert, M. Lloyd Jones |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2002-01-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta6290 |
Similar Items
-
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
by: J Kanis, et al.
Published: (2007-03-01) -
Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain
by: Darbà J, et al.
Published: (2015-02-01) -
A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
by: M Stevenson, et al.
Published: (2005-06-01) -
Modelling cost-effectiveness in osteoporosis
by: Kanis, J, et al.
Published: (2008) -
The cost-effectiveness of alendronate in the management of osteoporosis.
by: Kanis, J, et al.
Published: (2008)